{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T20:59:55Z","timestamp":1790197195139,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100013195","name":"William M Wood Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013195","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalimaging.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Imaging"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.clinimag.2026.110949","type":"journal-article","created":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T06:31:31Z","timestamp":1788589891000},"page":"110949","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Survival outcomes following thermal ablation of lung oligometastases categorized by the ESTRO-EORTC classification system"],"prefix":"10.1016","volume":"140","author":[{"given":"Julian A.","family":"Westphal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judit","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Graur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan A.","family":"Saenger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharath K.","family":"Bhagavatula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul B.","family":"Shyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muneeb","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian J.","family":"Fintelmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinimag.2026.110949_bb0005","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1200\/JOP.2017.026500","article-title":"Managing patients with Oligometastatic non-small-cell lung Cancer","volume":"14","author":"Stephens","year":"2018","journal-title":"J Oncol Pract"},{"key":"10.1016\/j.clinimag.2026.110949_bb0010","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1200\/JCO.2014.55.9567","article-title":"Radical irradiation of extracranial oligometastases","volume":"32","author":"Salama","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clinimag.2026.110949_bb0015","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ctrv.2016.11.003","article-title":"The expanding role of stereotactic body radiation therapy in oligometastatic solid tumors: what do we know and where are we going?","volume":"52","author":"Hong","year":"2017","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.clinimag.2026.110949_bb0020","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1200\/JCO.1995.13.1.8","article-title":"Oligometastases","volume":"13","author":"Hellman","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clinimag.2026.110949_bb0025","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1016\/S1470-2045(19)30718-1","article-title":"Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation","volume":"21","author":"Guckenberger","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clinimag.2026.110949_bb0030","doi-asserted-by":"crossref","first-page":"e173501","DOI":"10.1001\/jamaoncol.2017.3501","article-title":"Consolidative radiotherapy for limited metastatic non-small-cell lung cancer: a phase 2 randomized clinical trial","volume":"4","author":"Iyengar","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.clinimag.2026.110949_bb0035","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djx015","article-title":"Local treatment of unresectable colorectal liver metastases: results of a randomized phase II trial","volume":"109","author":"Ruers","year":"2017","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.clinimag.2026.110949_bb0040","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1200\/JCO.19.00201","article-title":"Local consolidative therapy vs. maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer: long-term results of a multi-institutional, phase II, randomized study","volume":"37","author":"Gomez","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clinimag.2026.110949_bb0045","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0022-5223(97)70397-0","article-title":"Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases","volume":"113","author":"Pastorino","year":"1997","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.clinimag.2026.110949_bb0050","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.diii.2020.09.006","article-title":"Radiofrequency ablation versus surgical resection for the treatment of oligometastatic lung disease","volume":"102","author":"Tselikas","year":"2021","journal-title":"Diagn Interv Imaging"},{"key":"10.1016\/j.clinimag.2026.110949_bb0055","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2214\/AJR.21.27099","article-title":"Update on image-guided thermal lung ablation: society guidelines, therapeutic alternatives, and postablation imaging findings","volume":"219","author":"Murphy","year":"2022","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.clinimag.2026.110949_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2023.107284","article-title":"Stereotactic body radiotherapy for lung oligo-metastases: systematic review and international stereotactic radiosurgery society practice guidelines","volume":"182","author":"Mayinger","year":"2023","journal-title":"Lung Cancer"},{"key":"10.1016\/j.clinimag.2026.110949_bb0065","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.athoracsur.2018.10.028","article-title":"Expert consensus document on pulmonary metastasectomy","volume":"107","author":"Handy","year":"2019","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.clinimag.2026.110949_bb0070","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1016\/S1470-2045(21)00528-3","article-title":"Definitive radiotherapy in lieu of systemic therapy for oligometastatic renal cell carcinoma: a single-arm, single-centre, feasibility, phase 2 trial","volume":"22","author":"Tang","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clinimag.2026.110949_bb0075","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.radonc.2022.01.019","article-title":"Evaluation of the prognostic value of the ESTRO EORTC classification of oligometastatic disease in patients treated with stereotactic body radiotherapy: a retrospective single center study","volume":"168","author":"Willmann","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clinimag.2026.110949_bb0080","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.radonc.2020.04.003","article-title":"Defining oligometastatic disease from a radiation oncology perspective: an ESTRO-ASTRO consensus document","volume":"148","author":"Lievens","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clinimag.2026.110949_bb0085","series-title":"Common Terminology Criteria for Adverse Events (CTCAE)","author":"U.S. Department of Health and Human Services","year":"2017"},{"key":"10.1016\/j.clinimag.2026.110949_bb0090","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.1245\/s10434-024-14910-z","article-title":"Multimodality management of thoracic tumors: initial experience with a multidisciplinary thoracic ablation conference","volume":"31","author":"Graur","year":"2024","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clinimag.2026.110949_bb0095","doi-asserted-by":"crossref","first-page":"5740","DOI":"10.1007\/s00330-023-09499-y","article-title":"Risk of persistent air leaks following percutaneous cryoablation and microwave ablation of peripheral lung tumors","volume":"33","author":"Abrishami Kashani","year":"2023","journal-title":"Eur Radiol"},{"key":"10.1016\/j.clinimag.2026.110949_bb0100","doi-asserted-by":"crossref","first-page":"e2330557","DOI":"10.2214\/AJR.23.30557","article-title":"High-frequency jet ventilation versus spontaneous respiration for percutaneous cryoablation of lung tumors: comparison of adverse events and procedural efficiency","volume":"222","author":"Graur","year":"2024","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.clinimag.2026.110949_bb0105","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ccm.2024.02.005","article-title":"Lung needle biopsy and lung ablation: indications, patient management, and postprocedure imaging findings","volume":"45","author":"Bhagavatula","year":"2024","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.clinimag.2026.110949_bb0110","doi-asserted-by":"crossref","first-page":"1242.e1","DOI":"10.1016\/j.jvir.2021.04.027","article-title":"Society of Interventional Radiology Quality Improvement Standards on percutaneous ablation of non-small cell lung cancer and metastatic disease to the lungs","volume":"32","author":"Genshaft","year":"2021","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.clinimag.2026.110949_bb0115","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2214\/AJR.23.29104","article-title":"Imaging follow-up of nonsurgical therapies for lung cancer: AJR expert panel narrative review","volume":"221","author":"Murphy","year":"2023","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.clinimag.2026.110949_bb0120","doi-asserted-by":"crossref","DOI":"10.1148\/ryct.250057","article-title":"Intercostal nerve protection using extrapleural air during percutaneous cryoablation of peripheral lung tumors","volume":"7","author":"Westphal","year":"2025","journal-title":"Radiol Cardiothorac Imaging"},{"key":"10.1016\/j.clinimag.2026.110949_bb0125","article-title":"Percutaneous thermal ablation of lung tumors: comparison of safety between overnight observation and same-day discharge in selected patients","author":"Alessi","year":"2025","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.clinimag.2026.110949_bb0130","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clinimag.2026.110949_bb0135","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1148\/radiol.14132958","article-title":"Image-guided tumor ablation: standardization of terminology and reporting criteria\u2014a 10-year update","volume":"273","author":"Ahmed","year":"2014","journal-title":"Radiology"},{"key":"10.1016\/j.clinimag.2026.110949_bb0140","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1016\/j.jtho.2021.07.021","article-title":"The ECLIPSE study: efficacy of cryoablation on metastatic lung tumors with a 5-year follow-up","volume":"16","author":"De Ba\u00e8re","year":"2021","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.clinimag.2026.110949_bb0145","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.jtho.2020.02.022","article-title":"Multicenter study of metastatic lung tumors targeted by interventional cryoablation evaluation (SOLSTICE)","volume":"15","author":"Callstrom","year":"2020","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.clinimag.2026.110949_bb0150","doi-asserted-by":"crossref","first-page":"iv192","DOI":"10.1093\/annonc\/mdy275","article-title":"Metastatic non-small cell lung cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"29","author":"Planchard","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clinimag.2026.110949_bb0155","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ejca.2017.12.012","article-title":"Strategies and technical challenges for imaging oligometastatic disease: recommendations from the European Organisation for Research and Treatment of Cancer imaging group","volume":"91","author":"deSouza","year":"2018","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clinimag.2026.110949_bb0160","doi-asserted-by":"crossref","first-page":"e534","DOI":"10.1016\/S1470-2045(18)30571-0","article-title":"Use of modern imaging methods to facilitate trials of metastasis-directed therapy for oligometastatic disease in prostate cancer: a consensus recommendation from the EORTC Imaging Group","volume":"19","author":"Lecouvet","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clinimag.2026.110949_bb0165","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1093\/annonc\/mds100","article-title":"Colorectal cancer pulmonary oligometastases: pooled analysis and construction of a clinical lung metastasectomy prognostic model","volume":"23","author":"Salah","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clinimag.2026.110949_bb0170","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1002\/bjs.7136","article-title":"Outcomes of intensive surveillance after resection of hepatic colorectal metastases","volume":"97","author":"Gomez","year":"2010","journal-title":"Br J Surg"},{"key":"10.1016\/j.clinimag.2026.110949_bb0175","doi-asserted-by":"crossref","first-page":"e406","DOI":"10.1016\/S1470-2045(16)30277-7","article-title":"Imaging oligometastatic cancer before local treatment","volume":"17","author":"Franklin","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clinimag.2026.110949_bb0180","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jvir.2024.10.017","article-title":"Microwave ablation of refractory oligometastatic non-small cell lung cancer in the liver","volume":"36","author":"Geevarghese","year":"2025","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.clinimag.2026.110949_bb0185","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.chest.2023.12.013","article-title":"Sublobar resection, stereotactic body radiation therapy, and percutaneous ablation provide comparable outcomes for lung metastasis-directed therapy","volume":"165","author":"Gits","year":"2024","journal-title":"Chest"},{"key":"10.1016\/j.clinimag.2026.110949_bb0190","doi-asserted-by":"crossref","first-page":"5895","DOI":"10.21873\/anticanres.14609","article-title":"Prognostic significance of oligometastatic disease classification by the ESTRO\/EORTC of cancer for patients with lung cancer treated with definitive radical radiotherapy","volume":"40","author":"Chen","year":"2020","journal-title":"Anticancer Res"},{"key":"10.1016\/j.clinimag.2026.110949_bb0195","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.ijrobp.2022.05.033","article-title":"Progression-free survival and local control after SABR for up to 5 oligometastases: an analysis from the population-based phase 2 SABR-5 trial","volume":"114","author":"Baker","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clinimag.2026.110949_bb0200","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.clon.2021.10.004","article-title":"Metastasis-directed therapy in prostate cancer: prognostic significance of the ESTRO\/EORTC classification in oligometastatic bone disease","volume":"34","author":"Nicholls","year":"2022","journal-title":"Clin Oncol"},{"key":"10.1016\/j.clinimag.2026.110949_bb0205","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/S0140-6736(18)32487-5","article-title":"Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial","volume":"393","author":"Palma","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.clinimag.2026.110949_bb0210","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.ijrobp.2022.06.067","article-title":"Completeness of reporting oligometastatic disease characteristics in the literature and influence on oligometastatic disease classification using the ESTRO\/EORTC nomenclature","volume":"114","author":"Nevens","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clinimag.2026.110949_bb0215","doi-asserted-by":"crossref","first-page":"494","DOI":"10.2214\/AJR.21.26551","article-title":"Comparison of percutaneous image-guided microwave ablation and cryoablation for sarcoma lung metastases: a 10-year experience","volume":"218","author":"Bourgouin","year":"2022","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.clinimag.2026.110949_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2023.107231","article-title":"Outcomes following cryoablation of stage IA non-small cell lung cancer in patients with and without interstitial lung disease: a retrospective single-center cohort study","volume":"181","author":"S\u00e4nger","year":"2023","journal-title":"Lung Cancer"},{"key":"10.1016\/j.clinimag.2026.110949_bb0225","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-51722-x","article-title":"Cryoablation and post-progression immune checkpoint inhibition in metastatic melanoma: a phase II trial","volume":"15","author":"Mooradian","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.clinimag.2026.110949_bb0230","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.jvir.2023.01.020","article-title":"Safety and effectiveness of percutaneous image-guided thermal ablation of juxtacardiac lung tumors","volume":"34","author":"Murphy","year":"2023","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.clinimag.2026.110949_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvir.2025.10.031","article-title":"Safety and effectiveness of non-small cell lung cancer cryoablation and microwave ablation involving previously irradiated lung","volume":"37","author":"Moscho","year":"2026","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.clinimag.2026.110949_bb0240","doi-asserted-by":"crossref","first-page":"e2330300","DOI":"10.2214\/AJR.23.30300","article-title":"Ablation of stage I\u2013II non-small cell lung cancer in patients with interstitial lung disease: a multicenter retrospective study","volume":"222","author":"Fintelmann","year":"2024","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.clinimag.2026.110949_bb0245","doi-asserted-by":"crossref","first-page":"5829","DOI":"10.1245\/s10434-021-09714-4","article-title":"Outcomes following percutaneous microwave and cryoablation of lung metastases from adenoid cystic carcinoma of the head and neck: a bi-institutional retrospective cohort study","volume":"28","author":"Leppelmann","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clinimag.2026.110949_bb0250","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1148\/radiol.2021203715","article-title":"Consensus guidelines for the definition of time-to-event end points in image-guided tumor ablation: results of the SIO and DATECAN initiative","volume":"301","author":"Puijk","year":"2021","journal-title":"Radiology"}],"container-title":["Clinical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089970712600241X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089970712600241X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T20:01:10Z","timestamp":1790193670000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S089970712600241X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":50,"alternative-id":["S089970712600241X"],"URL":"https:\/\/doi.org\/10.1016\/j.clinimag.2026.110949","relation":{},"ISSN":["0899-7071"],"issn-type":[{"value":"0899-7071","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Survival outcomes following thermal ablation of lung oligometastases categorized by the ESTRO-EORTC classification system","name":"articletitle","label":"Article Title"},{"value":"Clinical Imaging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinimag.2026.110949","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110949"}}